These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 16432691

  • 1. Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.
    Ogawa Y, Machida N, Ogawa T, Oda M, Hokama S, Chinen Y, Uchida A, Morozumi M, Sugaya K, Motoyoshi Y, Hattori M.
    Urol Res; 2006 Feb; 34(1):12-6. PubMed ID: 16432691
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
    Marangella M, Cosseddu D, Petrarulo M, Vitale C, Linari F.
    Nephrol Dial Transplant; 1993 Feb; 8(12):1333-7. PubMed ID: 8159301
    [Abstract] [Full Text] [Related]

  • 7. Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria.
    Hoppe B, Kemper MJ, Bökenkamp A, Langman CB.
    Kidney Int; 1998 Sep; 54(3):921-5. PubMed ID: 9734617
    [Abstract] [Full Text] [Related]

  • 8. Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria or oxalosis-unrelated renal diseases.
    Marangella M, Petrarulo M, Vitale C, Daniele PG, Sammartano S, Cosseddu D, Linari F.
    Clin Sci (Lond); 1991 Oct; 81(4):483-90. PubMed ID: 1657494
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL, Allie-Hamdulay S, Jackson GE, Sutton RA.
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.
    Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL.
    J Clin Invest; 1986 Jun; 77(6):1888-96. PubMed ID: 3711339
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of oral citrate administration in primary hyperoxaluria.
    Leumann E, Hoppe B, Neuhaus T, Blau N.
    Nephrol Dial Transplant; 1995 Jun; 10 Suppl 8():14-6. PubMed ID: 8592618
    [Abstract] [Full Text] [Related]

  • 15. Effect of magnesium oxide or citrate supplements on metabolic risk factors in kidney stone formers with idiopathic hyperoxaluria: a randomized clinical trial.
    Taheri M, Jalali S, Borumandnia N, Tavasoli S, Basiri A, Taheri F.
    Magnes Res; 2024 Jul 01; 37(1):12-21. PubMed ID: 39077820
    [Abstract] [Full Text] [Related]

  • 16. Management of primary hyperoxaluria: efficacy of oral citrate administration.
    Leumann E, Hoppe B, Neuhaus T.
    Pediatr Nephrol; 1993 Apr 01; 7(2):207-11. PubMed ID: 8476722
    [Abstract] [Full Text] [Related]

  • 17. Oxalate removal by hemodialysis in end-stage renal disease.
    Ramsay AG, Reed RG.
    Am J Kidney Dis; 1984 Sep 01; 4(2):123-7. PubMed ID: 6475942
    [Abstract] [Full Text] [Related]

  • 18. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO, Schmiedl A, Manoharan M.
    Clin Chem Lab Med; 2004 Mar 01; 42(3):283-93. PubMed ID: 15080561
    [Abstract] [Full Text] [Related]

  • 19. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
    Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF.
    Kidney Int; 2006 Nov 01; 70(9):1642-8. PubMed ID: 16955107
    [Abstract] [Full Text] [Related]

  • 20. Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
    Martin-Higueras C, Ludwig-Portugall I, Hoppe B, Kurts C.
    Nephrol Dial Transplant; 2019 Jun 01; 34(6):908-914. PubMed ID: 30169827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.